Clinical Trials Logo

Filter by:
NCT ID: NCT04368364 Terminated - Pain, Postoperative Clinical Trials

A Randomized Control Trial Comparing Analgesic Benefits of Ultrasound-guided Single vs Continuous Quadratus Lumborum Blocks (QLB)vs Intrathecal Morphine(ITM) for Post Cesarean Section Pain

Start date: May 22, 2020
Phase: Phase 4
Study type: Interventional

the purpose of this study is to compare opioid consumption in morphine equivalents between the groups that received postoperative analgesia with intrathecal morphine versus US guided QL blocks versus US guided QL catheters

NCT ID: NCT04368000 Terminated - COVID-19 Clinical Trials

Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization

PAPR
Start date: April 29, 2020
Phase: N/A
Study type: Interventional

Acute respiratory distress syndrome (ARDS) is a major complication among patients with severe disease. In a report of 138 patients with COVID-19, 20% developed ARDS at a median of 8 days after the onset of symptoms, with 12.3% of patients requiring mechanical ventilation. Efficacious therapies are desperately needed. Supportive care combined with intermittent prone positioning may improve outcomes. Prone positioning (PP) of patients with severe ARDS (when combined with other lung-protective ventilation strategies) is associated with a significant mortality benefit. In addition, PP for >12 hours in severe ARDS is strongly recommended by clinical practice guidelines. The aim of this study is to compare the outcomes of prone positioning versus usual care positioning in non-intubated patients hospitalized for COVID-19.

NCT ID: NCT04367467 Terminated - Breast Cancer Clinical Trials

Effect of PARP Inhibitors on Glomerular Filtration Rate

Start date: February 3, 2020
Phase:
Study type: Observational

The purpose of this study is to observe whether PARP inhibitors have an effect on serum creatinine level, and whether this reflects a change in creatinine secretion or a true change in kidney function.

NCT ID: NCT04366791 Terminated - Pneumonia Clinical Trials

Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19

RESCUE 1-19
Start date: April 24, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies low-dose radiation therapy as a focal anti-inflammatory treatment for patients with pneumonia or SARS associated with COVID-19 infection.

NCT ID: NCT04366310 Terminated - Clinical trials for Peripheral Perfusion

Capillary Refill Index With Rewarming

CRI
Start date: November 16, 2020
Phase:
Study type: Observational

A new technology, capillary refill index (CRI) can be useful for assessing peripheral perfusion status quantitatively, but this value can be influenced by fingertip temperature. The aim of this study is to evaluate the predictive accuracy of CRI after a temperature control (warming) procedure in predicting 30-day mortality among ICU/CCU patients. The investigators hypothesized that lowered fingertip temperature can lead prolonged CRI values which are considered as false positives in detection of high-risk patients for mortality, because it causes poor peripheral perfusion which does not reflect hemodynamic instability. The investigators will use the warming procedure to remove or reduce the effect of the fingertip temperature on the CRI measurement and will analyze whether it contributes to reduction of false positives in detection of high-risk patients for mortality.

NCT ID: NCT04365985 Terminated - COVID-19 Clinical Trials

Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19

SINK COVID-19
Start date: April 29, 2020
Phase: Phase 2
Study type: Interventional

Ideal new treatments for Novel Coronavirus-19 (COVID-19) would help halt the progression disease in patients with mild disease prior to the need for artificial respiration (ventilators), and also provide a rescue treatment for patients with severe disease, while also being affordable and available in quantities sufficient to treat large numbers of infected people. Low doses of Naltrexone, a drug approved for treating alcoholism and opiate addiction, as well as Ketamine, a drug approved as an anesthetic, may be able to interrupt the inflammation that causes the worst COVID-19 symptoms and prove an effective new treatment. This study will investigate their effectiveness in a randomized, blinded trial versus standard treatment plus placebo.

NCT ID: NCT04365673 Terminated - Hospitalism Clinical Trials

LACE+ and MRS Score Readmission Rate Assessment

Start date: July 7, 2020
Phase:
Study type: Observational

A study to demonstrate that the LACE+ score in non-inferior to the medication risk score when predicting 30-day readmission post hospital discharge.

NCT ID: NCT04365660 Terminated - Osteosarcoma Clinical Trials

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

Start date: January 28, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this research is to evaluate the study drug, 18F FTC-146, as a positron emission tomography (PET) / computed tomography (CT) radiotracer imaging agent to evaluate tumor status in patients newly diagnosed with osteosarcoma ("bone cancer").

NCT ID: NCT04365400 Terminated - Type 2 Diabetes Clinical Trials

Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes

TRIAGE
Start date: October 13, 2020
Phase: Phase 2
Study type: Interventional

To assess the efficacy and safety of orally administered Epeleuton capsules versus placebo, in the treatment of adult patients with hypertriglyceridemia and type 2 diabetes

NCT ID: NCT04365257 Terminated - COVID-19 Clinical Trials

Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)

PREVENT
Start date: May 13, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of prazosin to prevent cytokine storm syndrome and severe complications in hospitalized patients with Coronavirus disease 2019 (COVID-19).